XDx Announces Positive Results from European CARGO II Study of AlloMap(R …MarketWatch (press release)AlloMap is XDx's FDA-cleared and CE-marked, easy and convenient, non-invasive blood test that aids physicians in determining a stable heart trans…
Orgenesis Inc. Appoints Biotech Veteran to Board of DirectorsHealthcare Global (press release)The Company believes that converting the diabetic patient's own tissue into insulin-producing cells overcomes the problem of donor shortage and removes th…
Zacks Upgrades Alexion Pharmaceuticals to "Outperform" (ALXN)Junction Report… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the thera…
Orgenesis Inc. Appoints Biotech Veteran to Board of DirectorsSYS-CON Media (press release)The Company believes that converting the diabetic patient's own tissue into insulin-producing cells overcomes the problem of donor shortage and removes the ri…
Orgenesis Inc. Appoints Biotech Veteran to Board of DirectorsMarketWatch (press release)The Company believes that converting the diabetic patient's own tissue into insulin-producing cells overcomes the problem of donor shortage and removes the risk…
Harnessing Double Edged Sword PowersdailyRxThis discovery could lead to the development of drugs that may be useful in fighting cancer and preventing organ transplant rejection. Do all you can to keep your immune system humming along. Loyola researcher…
Synta – Exploring Galaxy And BeyondNASDAQ… ovarian cancer and under a phase I trial for acute myeloid leukemia; STA-9584 under preclinical development for prostate cancer and CRACM channel inhibitors, also under preclinical testing for chronic inflam…
Dx Focus: Quest Simplexa C. Diff Assay Gets FDA OK; XDx Begins AlloMap Testing …GenomeWebAlloMap is a non-invasive blood test that helps physicians to determine a stable heart transplant patient's risk of acute cellular rejection without using en…
Orgenesis Inc. Enters Into Agreement to Commence Advanced Studies for Proposed …Exec Digital (press release)The Company believes that converting the diabetic patient's own tissue into insulin-producing cells overcomes the problem of donor shortag…
Hamlin Names Cousin As Grand Marshall For The Denny Hamlin Short Track ShowdownPaddockTalkRecipients still face a life-long regimen of drugs to decrease the likelihood of transplant rejection. These drugs can increase the risk of infection, which, in t…